Differing physiological effects of epinephrine in type 1 diabetes and nondiabetic humans

American Journal of Physiology - Endocrinology and Metabolism

Volumn 288, Issue 1 51-1, 2005, Pages

  Guy, Deanna Aftab ^a   Sandoval, Darleen ^a   Richardson, M A ^a   Tate, Donna ^a   Flakoll, Paul J ^c   Davis, Stephen N ^a,b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c IOWA STATE UNIVERSITY   (United States)

Author keywords

Catecholamines; Epinephrine; Glucose clamp technique; Metabolic target organ

Indexed keywords

3 HYDROXYBUTYRIC ACID; ADRENALIN; FATTY ACID; GLUCAGON; GLUCOSE; GLYCEROL; GLYCOGEN SYNTHASE; INSULIN;

ADIPOSE TISSUE; ADRENALIN BLOOD LEVEL; ADULT; ARTICLE; CARDIOVASCULAR RESPONSE; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ENZYME ACTIVITY; ENZYME ASSAY; FATTY ACID BLOOD LEVEL; FEMALE; GLUCAGON BLOOD LEVEL; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TRANSPORT; GLYCEROL BLOOD LEVEL; HORMONE ACTION; HUMAN; HUMAN TISSUE; INFUSION; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; LIPOLYSIS; LIVER; MALE; MUSCLE; MUSCLE BIOPSY; PANCREAS; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE;

ADULT; AUTONOMIC NERVOUS SYSTEM; BIOPSY; BLOOD GLUCOSE; BLOOD PRESSURE; CALORIMETRY, INDIRECT; DIABETES MELLITUS, TYPE 1; EPINEPHRINE; FEMALE; GLUCAGON; GLUCOSE CLAMP TECHNIQUE; HEART RATE; HUMAN GROWTH HORMONE; HUMANS; HYDROCORTISONE; INSULIN; MALE; MUSCLE, SKELETAL; NOREPINEPHRINE; PANCREATIC POLYPEPTIDE; SYMPATHOMIMETICS;

EID: 11144303430     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.00310.2004     Document Type: Article

References (47)

1. Abumrad NN, Rabin D, Diamond MC, and Lacy WW. Use of a heated superficial hand vein as an alternative site for measurement of amino acid concentration and for the study of glucose and alanine kinetics in man.0 2. Metabolism 30: 936-940, 1981.
2. Aguilar-Parada E, Eisentraut AM, and Unger RH. Pancreatic glucagon secretion in normal and diabetic subjects. Am J Med Sci 257: 415-419, 1969.
3. Amiel SA, Tamborlane WV, Simonson DC, and Sherwin RS. Defective glucose counterregulation after strict control of insulin-dependent diabetes mellitus. N Engl J Med 316: 1376-1383, 1987.
4. Baron A and Brechtel G. Insulin differentially regulates systemic and skeletal muscle vascular resistance. Am J Physiol Endocrinol Metab 265: E61-E67, 1993.
5. Bergstrom J. Percutaneous needle biopsy of skeletal muscle in physiological and clinical research. Scand J Clin Lab Invest 35: 609-616, 1975.
6. Berk M, Clutter W, Skor D, Shah S, Gingerich R, Parvin C, and Cryer P, Enhanced glycemic responsiveness to epinephrine in insulin-dependent diabetes mellitus is the result of the inability to secrete insulin. J Clin Invest 75: 1842-1851, 1985.
7. Bolinder J, Sjoberg S, and Arner P, Stimulation of adipose tissue lipolysis following insulin-induced hypoglycemia: evidence of increased β-adrenoreceptor-mediated lipolytic response in IDDM. Diabetologia 39: 845-853, 1996.
8. Bruss ML and Black AL. Enzymatic microdetermination of glycogen. Annal Biochem 84: 309-312, 1978.
9. Causon R, Carruthers ME, and Rodnight R. Assay of plasma catecholamines by liquid chromatography with electrical detection. Annal Biochem 116: 223-226, 1981.
10. Cersosimo E, Garlick P, and Ferretti J. Abnormal glucose handling by the kidney in response to hypoglycemia in type 1 diabetes. Diabetes 50: 2087-2093, 2001.
11. Cherrington AD, Lacy WW, and Chiasson JL. Effect of glucagon on glucose production during insulin deficiency in the dog. J Clin Invest 62: 664-667, 1978.
12. Chu CA, Sherck S, Igawa K, Sindelar DK, Neal D, Emswiller MG, and Cherrington AD. Effects of free fatty acids on hepatic glycogenolysis and gluconeogenesis in conscious dogs. Am J Physiol Endocrinol Metab 282: E402-E411, 2002.
13. Cohen N, Halberstam M, Rossetti L, and Shamoon H. Increased lipid oxidation but normal muscle glycogen response to epinephrine in humans with IDDM. Am J Physiol Endocrinol Metab 271: E284-E293, 1996.
14. Cox D, Cryer PE, Gonder-Frederick L, Clarke WL, and Antain B. Perceived symptoms in the recognition of hypoglycemia. Diabetes Care 16: 519-527, 1993.
15. Davis SN, Fowler S, and Costa F. Hypoglycemic counterregulatory responses differ between men and women with type 1 diabetes. Diabetes 49: 65-72, 2000.
16. DeFronzo RA, Tobin K, and Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol Endocrinol Metab Gastrointest Physiol 237: E216-E223, 1979.
17. Deibert DC and DeFronzo RA. Epinephrine-induced insulin resistance in man. J Clin Invest 65: 717-721, 1980.
18. Exton J, Robinson GA, Sutherland W, and Park C. Studies on the role of adenosine 3′,5′-monophosphate in the hepatic actions of glucagon and catecholamines. J Biol Chem 246: 6166-6177, 1971.
19. Flakoll PJ, Zheng M, Vaughn S, and Borel M. Determination of stable isotopic enrichment and concentration of glycerol in plasma via gas chromatography-mass spectrometry for the estimation of lipolysis in vivo. J Chromotogr 7444: 47-54, 2000.
20. Frayn KN. Calculation of substrate oxidation rates in vivo from gaseous exchange. J Appl Physiol 55: 628-634, 1983.
21. Fritsche A, Stumvoll M, Grub M, Sieslack S, Renn W, Schmulling RM, Haring HU, and Gerich JE. Effect of hypoglycemia on beta-adrenergic sensitivity in normal and type 1 diabetic subjects. Diabetes Care 21: 1505-1510, 1998.
22. Gerich J, Lorenzi M, Tsalikian E, and Karam J. Studies on the mechanism of epinephrine-induced hyperglycemia in man. Diabetes 25: 65-71, 1976.
23. Gerich JE, Langlois M, Noacco C, Karam J, and Forsham PH. Lack of a glucagon response to hypoglycemia in diabetes: evidence for an intrinsic pancreatic alpha-cell defect. Science 182: 171-173, 1973.
24. Golden S, Wals PA, and Katz J. An improved procedure for the assay of glycogen synthase and phosphorylase in rat liver homogenates. Annal Biochem 77: 436-445, 1977.
25. Guinovart J, Salavert A, Massague J, Ciudad C, Salsas E, and Itarte E. Glycogen synthase: a new activity ratio assay expressing a high sensitivity to the phosphoyrlation state. FEBS Lett 106: 284-288, 1979.
26. Gustavson SM, Chu CA, Nishizawa M, Farmer B, Neal D, Yang Y, Donahue EP, Flakoll P, and Cherrington AD. Interaction of glucagon and epinephrine in the control of hepatic glucose production in the conscious dog. Am J Physiol Endocrinol Metab 284: E695-E707, 2003.
27. Gustavson SM, Chu CA, Nishizawa M, Farmer B, Neal D, Yang Y, Vaughan S, Donahue EP, Flakoll P, and Cherrington AD. Glucagon's actions are modified by the combination of epinephrine and gluconeogenic precursor infusion. Am J Physiol Endocrinol Metab 285: E534-E544, 2003.
28. Hagopian W, Lever E, Cen D, Emmounoud D, Polonsky K, Pugh W, Moosa A, and Jaspan JB. Preedominance of renal and absence of hepatic metabolism of pancreatic polypeptide in the dog. Am J Physiol Endocrinol Metab 245: E171-E177, 1983.
29. Ho RJ. Radiochemical assay of long chain fatty acid using 63NI as tracer. Annal Biochem 26: 105-113, 1970.
30. Hunter W and Greenwood F. Preparation of [131I]-labeled human growth hormone of high specific activity. Nature 194: 495-496, 1962.
31. Kaneto A, Miki E, and Kosaka K. Effect of beta and beta2 adrenoreceptor stimulants infused intrapancreatically on glucagon and insulin secretion. Endocrinology 97: 1166-1173, 1975.
32. Kasanicki MA and Pilch PF. Regulation of glucose-transporter function. Diabetes Care 13: 219-227, 1990.
33. Klip A and Marette A. Acute and chronic signals controlling glucose transport in skeletal muscle. J Cell Biochem 48: 51-60, 1992.
34. Lafontan M and Berlan M. Fat cell adrenergic receptors and the control of white and brown fat cell function. J Lipid Res 34: 1057-1091, 1993.
35. Laurent D, Falk Petersen K, Russell RR, Cline GW, and Shulman GI. Effect of epinephrine on muscle glycogenolysis and insulin-stimulated muscle glycogen synthesis in humans. Am J Physiol Endocrinol Metab 274: E130-E138, 1998.
36. Lloyd B, Burrin J, Smythe P, and Alberti KGMM. Enzymatic fluorometric continuous-flow assays for blood glucose lactate, pyruvate, alanine, glycerol, and 3-hydroxybutyrate. Clin Chem 24: 1724-1729, 1978.
37. Raz I. Epinephrine inhibits insulin-mediated glycogenesis but enhances glycolysis in human skeletal muscle. Am J Physiol Endocrinol Metab 260: E430-E435, 1991.
38. Rizza RA, Cryer PE, Haymond MW, and Gerich JE. Adrenergic mechanisms for the effects of epinephrine on glucose production and clearance in man. J Clin Invest 65: 682-689, 1980.
39. Rizza RA, Haymond MW, Cryer P, and Gerich J. Differential effects of epinephrine on glucose production and disposal in man. Am J Physiol Endocrinol Metab Gastrointest Physiol 237: E356-E362, 1979.
40. Russell RR, Chyun D, Song S, Sherwin RS, Tamborlane WV, Forrester AL, Pfeifer M, Rife F, Wackers F, and Young L. Cardiac responses to insulin-induced hypoglycemia in nondiabetic and intensively treated type 1 diabetic patients. Am J Physiol Endocrinol Metab 281: E1029-E1036, 2001.
41. Sacca L, Morrone G, Cicala M, Corso G, and Ungaro B. Influence of epinephrine, norepinephrine and isoproterenol on glucose homeostasis in normal man. J Clin Endocrinol Metab 50: 680-684, 1980.
42. Shamoon H, Hendler R, and Sherwin RS. Altered responsiveness to cortisol, epinephrine, and glucagon in insulin-infused juvenile-onset diabetics. Diabetes 29: 284-291, 1980.
43. Sherline P, Lynch A, and Glinsmann WH. Cyclic AMP and adrenergic receptor control of rat liver glycogen metabolism. Endocrinology 91: 680-690, 1972.
44. Sherwin RS, Kramer K, Robin J, and Andres R. A model of the kinetics of insulin in man. J Clin Invest 53: 1481-1492, 1974.
45. Stumvoll M, Chintalapudi U, Perriello G, Welle S, Gutierrez O, and Gerich J. Uptake and release of glucose by the human kidney. Postabsorptive rates and responses to epinephrine. J Clin Invest 96: 2528-2533, 1995.
46. Wall JS, Steele R, DeBodo RD, and Altszuler N. Effect of insulin on utilization and production of circulating glucose. Am J Physiol 189:43-50, 1957.
47. Wide L and Porath J. Radioimmunoassay of proteins with the use of sephadex-coupled antibodies. Biochim Biophys Acta 130: 257-260, 1966.